SAPROPTERIN

sapropterin dihydrochloride 100 mg soluble tablet, 30

SAPROPTERIN (12569M)

sapropterin dihydrochloride 100 mg soluble tablet, 30
12569M
Body System:
Manner of administration:Oral
General Schedule
Authority Required

Restriction

Indication: Maternal hyperphenylalaninaemia (HPA) due to phenylketonuria (PKU)
Treatment phase: Pre-conception through to when pregnancy first becomes known

Restriction

Indication: Maternal hyperphenylalaninaemia (HPA) due to phenylketonuria (PKU)
Treatment phase: Existing pregnancy to birth
Quantities & Cost
Max qty packs Max qty units # of repeats DPMQ Max safety net General Patient Charge
Max qty packs: 1 Max qty units: 30 # of repeats: 5 DPMQ: $833.22 Max safety net: $25.00 General Patient Charge: $25.00
Available brands
Kuvan